This validation step will be important to support conclusions from single-cell and/or single-nuclei RNA-seq, such as the hypothesised subtypes of the major brain cell types37 or that perturbed molecular profiles of different brain cell types could be involved in distinct processes in neurodegenerative diseases, such as AD18,37. Here, ADAM10 is linked to neurodegenerative disease.